Motley Fool have had VOC as a buy for quite some time now. Can't see that their long-standing buy recommendation would have suddenly translated into the 9% jump in the share price today.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%